LPCN · Lipocine Inc. · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-09-30 | Higuchi John W. |
Director |
Buy↑
|
Common stock
|
15,970 |
| 2026-09-29 | Higuchi John W. |
Director |
Buy↑
|
Common stock
|
9,037 |
| 2026-09-28 | Higuchi John W. |
Director |
Buy↑
|
Common stock
|
12,561 |
| 2026-08-03 | Grissinger Michael |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of August 3, 2027, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years. |
Stock Option (Right to Buy)
|
2,000 |
| 2026-06-29 | Patel Mahesh V. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to vesting whereby 1/3 of the shares subject to the award will vest on June 29, 2027 while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years. |
Stock Option (Right to Buy)
|
52,781 |
| 2026-06-03 | Ono Richard Dana |
Director |
Award↑
Filing footnotes — Common Stock (Right to Buy) (Direct)
100% vesting one year from date of grant. |
Common Stock (Right to Buy)
|
1,764 |
| 2026-06-03 | Jene Jill M. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
100% vesting one year from date of grant. |
Stock Option (Right to Buy)
|
1,764 |
| 2026-06-03 | Higuchi John W. |
Director |
Award↑
Filing footnotes — Common Stock (Right to Buy) (Direct)
100% vesting upon one year from date of grant. |
Common Stock (Right to Buy)
|
1,764 |
| 2026-04-07 | Higuchi John W. |
Director |
Buy↑
|
Common stock
|
40,000 |
| 2026-04-06 | Higuchi John W. |
Director |
Buy↑
|
Common stock
|
123,000 |
| 2026-04-06 | Patel Mahesh V. |
Director, Chief Executive Officer |
Buy↑
|
Common stock
|
25,000 |
| 2026-04-02 | Patel Mahesh V. |
Director, Chief Executive Officer |
Buy↑
|
Common stock
|
25,000 |
| 2026-01-02 | Patel Mahesh V. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to vesting whereby 1/3 of the shares subject to the award will vest on January 2, 2027, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years. |
Stock Option (Right to Buy)
|
25,000 |
| 2025-12-18 | Patel Mahesh V. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to vesting whereby 1/3 of the shares subject to the award will vest on December 18, 2026, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years. |
Stock Option (Right to Buy)
|
8,629 |
| 2025-12-18 | Fogarty Krista |
Principal Accounting Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to vesting whereby 1/3 of the shares subject to the award will vest on December 18, 2026, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years. |
Stock Option (Right to Buy)
|
20,786 |
| 2025-06-04 | Jene Jill M. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
100% vesting one year from date of grant. |
Stock Option (Right to Buy)
|
1,764 |
| 2025-06-04 | Ono Richard Dana |
Director |
Award↑
Filing footnotes — Common Stock (Right to Buy) (Direct)
100% vesting one year from date of grant. |
Common Stock (Right to Buy)
|
1,764 |
| 2025-06-04 | Papapetropoulos Spyros |
Director, President and CEO |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
100% vesting one year from date of grant. |
Stock Option (Right to Buy)
|
1,764 |
| 2025-06-04 | Fink Jeffrey Arvin |
Director |
Award↑
Filing footnotes — Common Stock (Right to Buy) (Direct)
100% vesting upon one year from date of grant. |
Common Stock (Right to Buy)
|
1,764 |
| 2025-06-04 | Higuchi John W. |
Director |
Award↑
Filing footnotes — Common Stock (Right to Buy) (Direct)
100% vesting upon one year from date of grant. |
Common Stock (Right to Buy)
|
1,764 |
| 2025-01-02 | Patel Mahesh V. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to vesting whereby 1/3 of the shares subject to the award will vest on January 2, 2026, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years. |
Stock Option (Right to Buy)
|
16,371 |
| 2024-12-23 | Fogarty Krista |
Principal Accounting Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to vesting whereby 1/3 of the shares subject to the award will vest on December 23, 2025, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years. |
Stock Option (Right to Buy)
|
5,943 |
| 2024-12-23 | Patel Mahesh V. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to vesting whereby 1/3 of the shares subject to the award will vest on December 23, 2025, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years. |
Stock Option (Right to Buy)
|
10,320 |
| 2024-06-05 | Papapetropoulos Spyros |
Director, President and CEO |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
100% vesting one year from date of grant. |
Stock Option (Right to Buy)
|
1,764 |
| 2024-06-05 | Jene Jill M. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
100% vesting one year from date of grant. |
Stock Option (Right to Buy)
|
1,764 |
| 2024-06-05 | Ono Richard Dana |
Director |
Award↑
|
Common Stock (Right to Buy)
|
1,764 |
| 2024-06-05 | Higuchi John W. |
Director |
Award↑
|
Common Stock (Right to Buy)
|
1,764 |
| 2024-06-05 | Fink Jeffrey Arvin |
Director |
Award↑
|
Common Stock (Right to Buy)
|
1,764 |
| 2024-03-08 | Patel Mahesh V. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted stock units subject to vesting whereby 1/3 of the shares subject to the award will vest on the one-year anniversary of March 8, 2025, while the remaining 2/3 of the shares subject to the award will vest semi-annually on a prorated basis over the following two years. |
Common Stock
|
4,893 |
| 2024-03-08 | Fogarty Krista |
Principal Accounting Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted stock unit subject to vesting whereby 1/3 of the shares subject to the award will vest on the one-year anniversary of March 8, 2025, while the remaining 2/3 of the shares subject to the award will vest semi-annually on a prorated basis over the following two years. |
Common Stock
|
991 |
| 2023-05-25 | Patel Mahesh V. |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
Prior to May 11, 2023, Mr. Patel held 1,678,090 shares of common stock. On May 11, 2023, the Company effected a reverse stock split at a ratio of 1-for17, which resulted in a change in Mr. Patel's shares of common stock to 98,712 as of May 11, 2023. |
Common Stock
|
8,706 |
| 2023-05-10 | Jene Jill M. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
100% vesting one year from date of grant. |
Stock Option (Right to Buy)
|
30,000 |
| 2023-05-10 | Papapetropoulos Spyros |
Director, President and CEO |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
100% vesting one year from date of grant. |
Stock Option (Right to Buy)
|
30,000 |
| 2023-05-10 | Higuchi John W. |
Director |
Award↑
|
Common Stock (Right to Buy)
|
30,000 |
| 2023-05-10 | Fink Jeffrey Arvin |
Director |
Award↑
|
Common Stock (Right to Buy)
|
30,000 |
| 2023-05-10 | Ono Richard Dana |
Director |
Award↑
|
Common Stock (Right to Buy)
|
30,000 |
| 2023-03-24 | Patel Mahesh V. |
Director, Chief Executive Officer |
Buy↑
|
Common Stock
|
150,000 |
| 2023-03-20 | Ono Richard Dana |
Director |
Buy↑
|
Common Stock
|
4,000 |
| 2023-03-17 | Patel Mahesh V. |
Director, Chief Executive Officer |
Buy↑
|
Common Stock
|
50,000 |
| 2023-01-03 | Patel Mahesh V. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 3,2024, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorate basis over the following two years. |
Stock Option (Right to Buy)
|
300,000 |
| 2022-12-22 | Fogarty Krista |
Principal Accounting Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 22, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years. |
Stock Option (Right to Buy)
|
91,850 |
| 2022-12-22 | Patel Mahesh V. |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of December 22, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years. |
Stock Option (Right to Buy)
|
112,500 |
| 2022-11-22 | Papapetropoulos Spyros |
Director, President and CEO |
Buy↑
|
Common stock
|
21,739 |
| 2022-11-14 | Patel Mahesh V. |
Director, Chief Executive Officer |
Buy↑
|
Common Stock
|
75,000 |
| 2022-11-01 | Nomikos George |
Chief Medical Officer |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of November 1, 2023, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorated basis over the following two years. |
Stock Option (Right to Buy)
|
125,000 |
| 2022-09-27 | Patel Mahesh V. |
Director, Chief Executive Officer |
Buy↑
|
Common Stock
|
100,000 |
| 2022-06-08 | Jene Jill M. |
Director |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
(1) 100% vesting one year from date of grant. |
Stock Option (Right to Buy)
|
22,000 |
| 2022-06-08 | Ono Richard Dana |
Director |
Award↑
|
Common Stock (Right to Buy)
|
22,000 |
| 2022-06-08 | Fink Jeffrey Arvin |
Director |
Award↑
|
Common Stock (Right to Buy)
|
22,000 |
| 2022-06-08 | Papapetropoulos Spyros |
Director, President and CEO |
Award↑
Filing footnotes — Stock Option (Right to Buy) (Direct)
Subject to vesting whereby all of the shares subject to the award will vest on the one year anniversary of June 8, 2023. |
Stock Option (Right to Buy)
|
22,000 |